BrainPatch’s Chief Science Officer, Dr Serhii Tukaiev, presented the company’s latest neurotechnology research at the European Congress of Psychiatry 2026 in Prague, marking his continued contribution to one of Europe’s leading mental health forums.
Read moreContinuing its series of strategic meetings across Asia, BrainPatch’s CEO Dr Nickolai Vysokov held discussions with Leave a Nest, a leading Japanese deep-tech platform, to explore future collaboration in neurotechnology and regional innovation.
Read moreThe Business Research Company forecasts the closed-loop neuromodulation processor market will reach $4.63 billion by 2030 (12.9% CAGR), citing AI-driven adaptive processors, wearable controllers and telemedicine integration; the report also highlights Medtronic's Feb 2025 FDA approvals and a 2023 Amber–Bioinduction acquisition.
Read moreA 2026 EEG‑rTMS study in 24 adults shows cortical beta oscillations separately encode uncertainty and movement preparation, and that beta‑frequency rTMS—especially when started at the beta trough—shortens reaction times and reduces beta desynchronisation.
Read moreParadromics launched an APEX Partnership Program to connect academic BCI researchers with its Connexus implantable interface; the FDA-approved Connect-One study aims to begin the first surgery in H1 2026.
Read moreIf you are looking for the best neurotechnology events, neurotech conferences, and brain-computer interface events in 2026 and 2027, this page brings them together in one place.
Read moreNeurology researchers published an evidence-based decision tool for deep brain stimulation on Mar 27, 2026; Parkinson’s patients in the report found the tool acceptable and rated its quality positively. The announcement did not include sample size or detailed outcome metrics and called for further evaluation.
Read moreCognito Therapeutics has joined Ochsner Health to pilot its investigational Spectris system—gamma-frequency light and sound neuromodulation—across the Gulf South, aiming to develop a Brain Health Index and gather real-world clinical and health-economics data.
Read moreTexas A&M researchers are developing an AI "digital human" that asks screening questions and analyzes facial expressions and biometrics to generate a "Digital Apathy Signature" aimed at improving early dementia detection.
Read moreColumbia psychologist Alexandra Muratore received the GFED Young Investigator Award to fund rTMS studies probing a brain circuit linked to restrictive eating in anorexia nervosa. The project will test whether non‑invasive magnetic stimulation changes symptoms and could inform mechanism‑based treatments.
Read moreEMOTIV has published an Ubuntu beta of its Launcher app, providing a single-login hub for EMOTIV EEG headsets and apps with raw-data capture, BCI controls, device management, and a Virtual Brainwear simulator.
Read moreSharif University researchers report a polydopamine-doped PEDOT coating that cuts 1 kHz impedance to ~270 Ω, makes the surface superhydrophilic, and increases cell adhesion in vitro; molecular dynamics show stronger membrane binding for PDA-containing interfaces.
Read moreBoston University researchers show that the neurovascular impulse response linking neural activity to blood volume varies across cortical regions in mice and reflects local neuromodulatory signals; data and code are publicly available on DANDI and GitHub.
Read moreA multicohort ENIGMA study published in The Lancet Digital Health finds that large strokes speed aging in damaged tissue while making contralesional frontoparietal regions appear younger; the pattern correlates with severe, persistent motor deficits and may reflect compensatory neuroplasticity.
Read moreA mouse study in Alcohol Clinical & Experimental Research finds that drinking to cope with stress in early adulthood produced lasting locus coeruleus dysfunction, higher oxidative stress, and midlife cognitive deficits in mice; human implications remain unproven.
Read moreAvation Medical appoints co-founder Manish Vaishya, PhD as CEO and closes Series D financing to scale commercialization and reimbursement for its FDA-cleared Vivally wearable neuromodulation system for overactive bladder.
Read more